Metronidazole API BP/USP

Metronidazole is a well-established nitroimidazole antimicrobial agent indicated for the treatment of a broad spectrum of anaerobic bacterial and protozoal infections. Clinically proven to be effective in managing conditions such as bacterial vaginosis, trichomoniasis, amoebiasis, and various gastrointestinal infections, it remains a cornerstone therapy in both hospital and outpatient settings.

Salius Pharma delivers high-purity Metronidazole in both API and Finished Dosage Forms (oral, injectable, and topical), adhering to global GMP standards. As a WHO-listed essential medicine, Metronidazole from Salius is produced with a strong focus on quality, consistency, and regulatory compliance to meet international market demands.